EXELON caps 6 mg 112 pce

7680542752181 CH-54275 N06DA03 01.99.0.

Reimbursement limitations:

THERAPIEBEG

En début de thérapie, application par ex. d'un test minimental.
Première évaluation intermédiaire après trois …

EXELON caps 6 mg 112 pce
EXELON caps 6 mg 112 pce
EXELON caps 6 mg 112 pce
1 / 3
google

Details

Product number
5427506
CPT
-
Packaging group
112
Unit
Kapsel(n)
Composition
rivastigminum 6 mg ut rivastigmini hydrogenotartras, silica colloidalis anhydrica, hypromellosum, magnesii stearas, cellulosum microcristallinum, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (rubrum), pro capsula.

Articles (1)

Exelon 6 mg, Kapseln
Kapseln
112
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/04/2025
Patient information leaflet
Français
25/04/2025
Patient information leaflet
Italien
25/04/2025
Professional SmPC
Allemand
25/04/2025
Professional SmPC
Français
25/04/2025
Professional SmPC
Italien
25/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
6.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 117.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
54275
Drug name
Exelon, Kapseln
Galenic form
KAHA
ATC Code
N06DA03
Authorization status
Z
Dispensation category
B
First authorization
31/07/1997
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine
Field of application
Demenz vom Alzheimer Typ, Demenz bei Parkinson Krankheit

Packaging details

Description (FR)
EXELON caps 6 mg 112 pce
Description (DE)
EXELON Kaps 6 mg 112 Stk
Market launch
31/07/1997
Narcotic (BTM)
No

Available generics

Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 59.40
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 59.40
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 102.35
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 59.40
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 102.35
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 59.40
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 59.40
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 102.35
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 59.40
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 102.35
View

Other packaging sizes

EXELON caps 1.5 mg 28 pce
28 KAP
View
EXELON caps 1.5 mg 56 pce
56 KAP
View
EXELON caps 1.5 mg 112 pce
112 KAP
View
EXELON caps 3 mg 28 pce
28 KAP
View
EXELON caps 3 mg 56 pce
56 KAP
View
EXELON caps 3 mg 112 pce
112 KAP
View
EXELON caps 4.5 mg 28 pce
28 KAP
View
EXELON caps 4.5 mg 112 pce
112 KAP
View
EXELON caps 6 mg 28 pce
28 KAP
View